v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net loss $ (10,442,485) $ (7,852,659)
Adjustments to reconcile net loss to net cash used in operations    
Stock-based compensation expense 6,313,167 1,920,805
Unrealized loss on short-term investments 35,212
Change in operating assets and liabilities:    
Prepaid expenses 26,583 189,073
Other receivables 11,862
Trade accounts payable and accrued expenses (594,146) 184,785
Related party accrued interest (14,472)
Net cash used in operating activities (4,661,669) (5,560,606)
Financing activities:    
Offering costs (292,470)
Proceeds from related party 572,865
Proceeds from Common stock option exercises 888,282
Advances from (to) affiliates 33,713
Bayshore Trust short-swing disgorgement 148,703
Proceeds from sale of common stock 7,006,982 3,608,555
Net cash provided by financing activities 8,175,659 3,790,971
Net increase (decrease) in cash 3,513,990 (1,769,635)
Cash, beginning of year 2,832,931 4,602,566
Cash, end of year 6,346,921 2,832,931
Supplemental disclosure of cash flow information    
Cash paid for interest
Cash paid for income taxes
Supplemental schedule of non-cash financing activities:    
Deferred offering costs charged to additional paid-in capital 32,500
Issuance of common stock for the short-term investments, SKNY acquisition $ 4,718,311